SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific informs about press release

08 Apr 2020 Evaluate

Sequent Scientific has informed that the company has enclosed a copy of Press Release that is being issued by the Company today, 08th April 2020 regarding ‘Sequent Scientific provides Covid-19 and Business Update’.

The above information is a part of company’s filings submitted to BSE.


Viyash Scientific Share Price

249.50 -2.40 (-0.95%)
11-Jun-2026 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.75
Dr. Reddys Lab 1275.00
Cipla 1382.85
Zydus Lifesciences 1106.20
Lupin 2277.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: